SCHEMBL6629787

SCHEMBL6629787

C#CCOC1OCCC1Br.C=C1CC2CCOC2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1273196 0.80 CHRM2 (0.33)
SCHEMBL6630936 0.73
Furan SCHEMBL7495514 0.72
SCHEMBL20141502 0.71 CHRM2 (0.32)
SCHEMBL20141501 0.71 CHRM2 (0.32)
SCHEMBL20141503 0.71 CHRM2 (0.32)
SCHEMBL1273146 0.65
SCHEMBL8343290 0.64 CHRM2 (0.37)
SCHEMBL1491239 0.64 CHRM2 (0.37)
SCHEMBL1491238 0.64 CHRM2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404680-A2 PROCESS FOR PREPARING INTERMEDIATES OF HIV PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-04-07 EP disclosed
WO-2002067239-A2 PROCESS FOR PREPARING INTERMEDIATES OF HIV PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2002-08-29 WO disclosed